ScinoPharm Taiwan, Ltd. (TPE:1789)

ScinoPharm Taiwan Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 30, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	18,661	17,436	20,876	20,124	19,492	22,813
Market Cap Growth	6.31%	-16.48%	3.73%	3.25%	-14.56%	8.46%
Enterprise Value	16,587	14,136	17,530	16,527	16,275	19,607
Last Close Price	23.60	21.60	25.60	24.37	23.17	26.56
PE Ratio	98.26	51.38	72.72	56.98	80.06	80.88
Forward PE	62.11	63.98	63.98	52.60	30.88	115.41
PS Ratio	5.85	5.12	6.55	6.17	7.06	7.40
PB Ratio	1.70	1.66	2.01	1.93	1.85	2.17
P/TBV Ratio	1.70	1.66	2.02	1.93	1.86	2.17
P/FCF Ratio	75.31	37.04	-	37.93	99.76	29.77
P/OCF Ratio	36.84	23.22	90.32	26.01	38.23	24.11
EV/Sales Ratio	5.20	4.15	5.50	5.06	5.89	6.36
EV/EBITDA Ratio	24.54	17.85	23.07	19.93	24.83	25.99
EV/EBIT Ratio	99.27	44.03	55.74	40.76	56.39	52.18
EV/FCF Ratio	66.94	30.03	-	31.15	83.29	25.59
Debt / Equity Ratio	0.07	0.06	0.06	0.07	0.05	0.06
Debt / EBITDA Ratio	1.15	0.83	0.80	0.80	0.83	0.75
Debt / FCF Ratio	3.13	1.44	-	1.28	2.85	0.75
Asset Turnover	0.27	0.29	0.27	0.28	0.24	0.26
Inventory Turnover	1.09	1.32	1.46	1.59	1.14	1.49
Quick Ratio	4.83	6.28	6.52	6.16	8.04	6.59
Current Ratio	7.85	8.61	8.75	7.87	10.73	8.62
Return on Equity (ROE)	1.80%	3.25%	2.76%	3.37%	2.31%	2.71%
Return on Assets (ROA)	0.87%	1.70%	1.66%	2.15%	1.53%	2.00%
Return on Invested Capital (ROIC)	1.62%	3.75%	3.73%	4.73%	3.31%	4.03%
Return on Capital Employed (ROCE)	1.40%	2.90%	2.90%	3.70%	2.60%	3.40%
Earnings Yield	1.03%	1.95%	1.38%	1.75%	1.25%	1.24%
FCF Yield	1.33%	2.70%	-0.18%	2.64%	1.00%	3.36%
Dividend Yield	1.42%	1.62%	1.17%	1.48%	2.07%	1.88%
Payout Ratio	143.39%	69.91%	99.17%	107.46%	162.39%	75.69%
Buyback Yield / Dilution	0.03%	-0.07%	0.04%	-0.05%	-0.01%	-0.01%
Total Shareholder Return	1.44%	1.55%	1.22%	1.43%	2.06%	1.87%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.